Mobile Site ›
Hot Topics Banner

Warfarin Sensitivity Genotyping



August 2008

Use of Mayo’s recently introduced warfarin sensitivity genotyping test in the identification of patients at risk of warfarin-associated bleeding is discussed.

Presenter:

Print Options

Additional information:

See Warfarin: Genotyping and improving dosing in the August 2008 issue of Communiqué.

Warfarin genotyping is just one of the tests that Mayo Medical Laboratories offers to identify those patients with abnormal drug metabolism. Testing is also available for the cytochrome P450 polymorphisms:

  • Cytochrome P450 2C19 Genotype
  • Cytochrome P450 2C9 Genotype

Forward to a Colleague

Share this presentation

If you have questions, e-mail


Key